Dec 1, 2025 05:09AM RBC Capital Downgrades Sionna Therapeutics (SION) to Underperform

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Nov 5, 2025 10:50AM Raymond James Positive on Sionna Therapeutics (SION): 'continue to like the set-up into initial POC data next year'

Oct 17, 2025 10:16AM Freedom Capital Markets Starts Sionna Therapeutics (SION) at Buy

Sep 8, 2025 08:02AM Sionna Therapeutics names Caroline Stark Beer as chief business officer

Sep 8, 2025 07:02AM Jones Trading Starts Sionna Therapeutics (SION) at Buy, PT $46

Sep 3, 2025 05:11AM RBC Capital Starts Sionna Therapeutics (SION) at Sector Perform

Aug 12, 2025 01:41AM Sionna Therapeutics (SION) Misses Q2 EPS by 41c

Aug 11, 2025 12:05PM Guggenheim on Sionna Therapeutics (SION): 'we continue to believe SION has the potential to revolutionize the cystic fibrosis treatment paradigm with its first-in-class NBD1 stabilizers'

Jun 6, 2025 11:00AM Sionna Therapeutics (SION) Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model

Jun 4, 2025 09:05AM Stifel on Sionna Therapeutics (SION): 'both compounds are able to attain exposures well above the modeled PK threshold'

Jun 4, 2025 07:00AM Sionna Therapeutics (SION) Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451

May 13, 2025 06:29AM Sionna Therapeutics, Inc. (SION) Reports Q1 Loss of $0.62

Mar 20, 2025 04:15PM (SION) Misses Q4 EPS by 338c

Mar 20, 2025 11:47AM Stifel on Sionna Therapeutics (SION): 'we like the stock set up here'

Mar 4, 2025 06:14AM TD Cowen Starts Sionna Therapeutics (SION) at Buy

Mar 4, 2025 01:08AM Stifel Starts Sionna Therapeutics (SION) at Buy

Mar 4, 2025 01:07AM Guggenheim Starts Sionna Therapeutics (SION) at Buy